Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
HZNP Horizon Pharma Public Limited Company daily Stock Chart
HZNP [NASD]
Horizon Pharma Public Limited Company
Healthcare | Drugs - Generic | Ireland
financial highlights | statements
Index- P/E- EPS (ttm)-3.37 Insider Own0.70% Shs Outstand164.61M Perf Week0.20%
Market Cap2.47B Forward P/E8.13 EPS next Y1.85 Insider Trans0.00% Shs Float163.61M Perf Month9.48%
Income-552.30M PEG- EPS next Q0.31 Inst Own91.50% Short Float5.96% Perf Quarter8.14%
Sales1.06B P/S2.33 EPS this Y-186.70% Inst Trans-1.19% Short Ratio4.98 Perf Half Y11.35%
Book/sh5.23 P/B2.87 EPS next Y21.37% ROA-11.50% Target Price19.58 Perf Year42.95%
Cash/sh4.10 P/C3.66 EPS next 5Y18.90% ROE-49.20% 52W Range9.90 - 16.02 Perf YTD2.81%
Dividend- P/FCF12.84 EPS past 5Y-5.70% ROI-12.60% 52W High-6.24% Beta1.32
Dividend %- Quick Ratio1.50 Sales past 5Y123.70% Gross Margin50.60% 52W Low51.72% ATR0.52
Employees300 Current Ratio1.60 Sales Q/Q1.40% Oper. Margin-39.20% RSI (14)60.82 Volatility1.99% 3.82%
OptionableYes Debt/Eq2.21 EPS Q/Q-71.00% Profit Margin-45.10% Rel Volume0.13 Prev Close15.01
ShortableYes LT Debt/Eq2.17 EarningsMay 09 BMO Payout- Avg Volume1.96M Price15.02
Recom1.80 SMA205.30% SMA505.71% SMA2007.21% Volume12,350 Change0.07%
Jan-12-18Upgrade Mizuho Neutral → Buy $12 → $18
Sep-28-17Initiated Goldman Buy $16
Jun-16-17Initiated Cantor Fitzgerald Overweight $13
May-09-17Reiterated Stifel Buy $35 → $20
May-09-17Downgrade Mizuho Buy → Neutral $22 → $10
Feb-28-17Reiterated Mizuho Buy $25 → $22
Dec-16-16Upgrade Mizuho Neutral → Buy $14 → $25
Dec-09-16Downgrade Mizuho Buy → Neutral $30 → $14
Nov-28-16Upgrade Citigroup Neutral → Buy
Nov-08-16Reiterated Mizuho Buy $29 → $30
Oct-31-16Reiterated Mizuho Buy $33 → $29
Sep-13-16Reiterated Mizuho Buy $30 → $33
Jul-11-16Upgrade Morgan Stanley Underweight → Equal-Weight $24
Jun-06-16Initiated Goldman Buy $24
May-10-16Reiterated Mizuho Buy $25 → $24
May-03-16Reiterated Mizuho Buy $34 → $25
Jan-19-16Resumed Jefferies Buy $31
Jan-06-16Resumed Citigroup Neutral
Dec-17-15Initiated Goldman Buy
Dec-14-15Reiterated Mizuho Buy $34 → $36
May-22-18 09:00AM  Horizon Pharma plc Launches GoutRevealed.com to Spotlight the Journey and Stories of People Living with Uncontrolled Gout GlobeNewswire
May-14-18 02:54PM  Phase two of clinical gout trial begins at UAB American City Business Journals +5.12%
May-11-18 07:46PM  Edited Transcript of HZNP earnings conference call or presentation 9-May-18 12:00pm GMT Thomson Reuters StreetEvents
07:00AM  Free Daily Technical Summary Reports on Horizon Pharma and Three More Generic Drugs Stocks ACCESSWIRE
May-10-18 10:33AM  Horizon Pharma (HZNP) Q1 Earnings & Sales Miss, Shares Fall Zacks
08:30AM  Today's Research Reports on Trending Tickers: Horizon Pharma and Ironwood Pharmaceuticals ACCESSWIRE
May-09-18 08:00AM  Horizon Pharma (HZNP) Q1 Loss Wider, Revenues Miss Zacks -5.60%
07:35AM  Horizon Pharma: 1Q Earnings Snapshot Associated Press
07:00AM  Horizon Pharma plc Reports Strong First-Quarter 2018 Orphan and Rheumatology Net Sales Growth; Increases Full-Year 2018 Guidance and Announces New Company Operating Structure to Enhance Focus on Rare Diseases GlobeNewswire
May-08-18 12:51PM  What Are Analysts Saying About Horizon Pharma Public Limited Companys (NASDAQ:HZNP) Earnings Trajectory? Simply Wall St.
08:00AM  Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of Additional Notices of Allowance With Claims Covering RAVICTI® (glycerol phenylbutyrate) Oral Liquid GlobeNewswire
May-04-18 08:00AM  Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
May-03-18 08:39AM  Zacks.com highlights: Western Digital, Daqo New Energy, Horizon Pharma Public and American Axle & Manufacturing Holdings Zacks
08:00AM  Horizon Pharma plc Announces Sangita Iyer as a 2018 Healthcare Businesswomens Association Rising Star GlobeNewswire
May-02-18 08:16AM  4 Low P/CF Stocks Ready to Add Value to Your Investment Zacks
May-01-18 08:00AM  Horizon Pharma plc to Participate in the UBS Global Healthcare Conference GlobeNewswire +6.95%
Apr-20-18 08:39AM  Eleven Biotherapeutics (EBIO) in Focus: Stock Moves 8.7% Higher Zacks
Apr-18-18 06:33AM  Zacks.com highlights: Western Digital, ArcelorMittal, Arrow Electronics and Horizon Pharma Public Zacks
Apr-17-18 09:38AM  Pick These 4 Low P/CF Stocks & Sail Through a Volatile Market Zacks
Apr-12-18 04:30PM  Horizon Pharma plc Named No. 1 Biopharma Company to Work for by Great Place to Work® and FORTUNE GlobeNewswire
Apr-11-18 08:20AM  New Research: Key Drivers of Growth for Talend S.A, Chipmos Technologies, POSCO, Horizon Pharma Public, BioSpecifics Technologies, and Arbutus Biopharma Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Apr-09-18 08:00AM  Horizon Pharma plc to Release First-Quarter 2018 Financial Results and Host Webcast on May 9, 2018 GlobeNewswire
Apr-06-18 09:27AM  4 Drug/Biotech Stocks to Buy Ahead of World Health Day Zacks
05:00AM  When These New Pharma Bros Show Up, Drug Prices Tend to Go Monumentally Higher Bloomberg
Apr-05-18 10:37AM  Conatus' Emricasan Fails in Phase II Study, Shares Sink Zacks
Apr-04-18 08:00AM  Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Apr-02-18 09:56AM  Amgen's Blincyto Gets FDA Nod for Minimum Residual Disease Zacks
05:56AM  Horizon Pharma (HZNP) Down 3.9% Since Earnings Report: Can It Rebound? Zacks
Mar-31-18 07:00AM  3 Top Value Stocks to Buy Right Now Motley Fool
Mar-29-18 05:31PM  Edited Transcript of HZNP earnings conference call or presentation 28-Feb-18 1:00pm GMT Thomson Reuters StreetEvents
07:45AM  Is a Recession in the Cards? 4 Safe Bets for Your Portfolio Zacks
Mar-27-18 10:08AM  Protagonist Therapeutics Stalls Ulcerative Colitis Study Zacks
Mar-26-18 10:20AM  Pfizer's Chantix Fails in Phase IV Study in Young Smokers Zacks
09:40AM  Clovis Gets Positive CHMP Opinion for Ovarian Cancer Drug Zacks
Mar-21-18 10:55AM  Seattle Genetics' Adcetris Gets FDA Nod for Label Expansion Zacks
08:47AM  Ignore Trump's Pricing Rhetoric With These 5 Biotech Picks Zacks
Mar-20-18 11:49AM  Heron's Pain Candidate Meets Endpoint in Pivotal Studies Zacks
11:43AM  Arena's (ARNA) Etrasimod Meets Phase II Colitis Study Goal Zacks
Mar-19-18 10:18AM  Geron (GERN) Q4 Loss Flat Y/Y, Revenues Surge, Shares Up Zacks
Mar-15-18 10:00AM  Is Horizon Pharma Public (HZNP) a Great Stock for Value Investors Right Now? Zacks
08:09AM  Physicians And Patients Finally Avoiding Horizon's Expensive, Low-Value Pain Drugs Duexis And Vimovo Forbes
Mar-13-18 04:32PM  Cantor Fitzgerald Names 8 Upcoming Biotech Catalysts Benzinga
11:20AM  Sarepta to Seek Rapid Approval for Second DMD Drug, Stock Up Zacks
07:30AM  Investor Expectations to Drive Momentum within Methanex, YPF Sociedad Anonima, Adaptimmune Therapeutics, Horizon Pharma, Changyou, and China Yuchai International Discovering Underlying Factors of Influence GlobeNewswire
Mar-12-18 09:15AM  Zacks.com highlights: TheStreet, Barclays, Horizon Pharma, Regions Financial and TechTarget Zacks
Mar-09-18 06:32AM  5 Cheap Breakout Stocks for Explosive Returns Zacks
Mar-07-18 07:10AM  Wired News Zynerba Pharma Held Positive Discussion Meeting with FDA for its ZYN002 Development Strategy ACCESSWIRE
Mar-06-18 04:05PM  Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Mar-02-18 10:01AM  Horizon Pharma (HZNP) Tops Q4 Earnings, Provides 2018 View Zacks
Feb-28-18 08:45AM  Horizon Pharma reports 4Q loss Associated Press
08:43AM  Are Horizon Pharma Public Limited Companys (NASDAQ:HZNP) Interest Costs Too High? Simply Wall St.
08:25AM  Horizon Pharma (HZNP) Tops Q4 Earnings, Revenues Beat Zacks
07:00AM  Horizon Pharma plc Announces Fourth-Quarter and Full-Year 2017 Results GlobeNewswire
Feb-27-18 06:00PM  Horizon Pharma plc Submits Supplemental New Drug Application for RAVICTI® (glycerol phenylbutyrate) Oral Liquid to Expand Age Range to Include Newborns GlobeNewswire
Feb-26-18 08:00AM  Horizon Pharma Gift Establishes First Clinical Team Endowment at Childrens National Rare Disease Institute GlobeNewswire
07:00AM  Horizon Pharma plc to Participate in the Cowen and Company 38th Annual Health Care Conference GlobeNewswire
Feb-23-18 09:26AM  Is a Beat in Store for Horizon Pharma (HZNP) in Q4 Earnings? Zacks
Feb-22-18 09:00AM  Horizon Pharma plc Announces Release of the First RAREis Song in Partnership with Sing Me a Story Foundation and Global Genes GlobeNewswire
Feb-15-18 02:12AM  [$$] Irish drugmaker Horizon Pharma raises painkiller price to $3,000 in US Financial Times
Feb-06-18 04:05PM  Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Jan-30-18 08:30AM  Horizon Pharma plc Announces the Launch of Cystinosis United to Educate, Inspire and Connect the Cystinosis Community GlobeNewswire
Jan-29-18 08:00AM  Horizon Pharma plc to Release Fourth-Quarter and Full-Year 2017 Financial Results and Host Webcast on Feb. 28, 2018 GlobeNewswire
Jan-15-18 07:30AM  Nuvo Pharmaceuticals (Ireland) Limited Acquires U.S. Product Rights to Resultz® from Piedmont Pharmaceuticals LLC CNW Group
Jan-09-18 03:57PM  U.S. pharma executives expect deals to pick up after tax overhaul Reuters
01:24PM  U.S. pharma executives expect deals to pick up after tax overhaul Reuters
08:07AM  See what the IHS Markit Score report has to say about Horizon Pharma PLC. Markit
Jan-08-18 08:32AM  What Does Horizon Pharma Public Limited Companys (NASDAQ:HZNP) Share Price Indicate? Simply Wall St.
07:05AM  Horizon Pharma plc Increases Peak Net Sales Guidance for Key Growth Drivers and Announces Rheumatology and Orphan Pipeline Developments GlobeNewswire
07:00AM  Horizon Pharma plc Announces Agreement to License Pre-Clinical Uricase Derivative (MEDI4945) from MedImmune GlobeNewswire
Jan-05-18 04:05PM  Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Jan-04-18 09:17AM  How Analysts Rated Jazz Pharmaceuticals in December Market Realist
07:30AM  Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Jan-02-18 08:07AM  See what the IHS Markit Score report has to say about Horizon Pharma PLC. Markit
07:30AM  Nuvo Pharmaceuticals Inc. Acquires Global ex-U.S. Product Rights and existing Royalty Streams to Resultz® from Piedmont Pharmaceuticals LLC CNW Group
Dec-31-17 03:00PM  3 Top Value Stocks to Buy in 2018 Motley Fool
Dec-28-17 09:21AM  Horizon Pharma Gets FDA Nod for Procysbi Label Expansion Zacks
Dec-27-17 11:21AM  ETFs with exposure to Horizon Pharma Plc : December 27, 2017 Capital Cube
08:35AM  Horizon Pharma shares jump 3% premarket after FDA expands use of treatment for metabolic disorder MarketWatch
08:00AM  Horizon Pharma plc Announces FDA Approval to Expand the Indication for PROCYSBI® (cysteamine bitartrate) Delayed-Release Capsules to Include Children One Year of Age and Older Living with Nephropathic Cystinosis GlobeNewswire
03:00AM  Horizon Pharma Shows Improved Relative Price Performance; Still Shy Of Benchmark Investor's Business Daily
Dec-18-17 09:23AM  Horizon Pharma plc to Present at the 36th Annual J.P. Morgan Healthcare Conference GlobeNewswire
07:50AM  Free Research Report as Horizon Pharmas Revenue Grew 30.2% ACCESSWIRE
Dec-15-17 03:00AM  Stocks With Rising Relative Price Strength: Horizon Pharma Investor's Business Daily
Dec-14-17 07:30AM  Nuvo Pharmaceuticals Enters into Pennsaid® 2% License Agreement with Gebro Pharma AG for Switzerland and Liechtenstein CNW Group
03:00AM  Horizon Pharma Earns RS Rating Upgrade Investor's Business Daily
Dec-12-17 10:32AM  Analysts Recommendations for BioMarin in December 2017 Market Realist
Dec-05-17 04:05PM  Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Dec-04-17 11:01AM  ETFs with exposure to Horizon Pharma Plc : December 4, 2017 Capital Cube
Dec-01-17 08:10AM  Todays Research Reports on Stocks to Watch: Horizon Pharma and Insmed Incorporated ACCESSWIRE
Nov-30-17 04:05PM  Horizon Pharma plc to Participate in BMO Prescriptions for Success Healthcare Conference GlobeNewswire
07:30AM  Nuvo Pharmaceuticals Announces Normal Course Issuer Bid CNW Group
06:00AM  Horizon Pharma plc Names Shao-Lee Lin, M.D., Ph.D. Executive Vice President, Research and Development and Chief Scientific Officer GlobeNewswire
Nov-28-17 07:00AM  Nuvo Pharmaceuticals Commences Trading on the OTCQX® Market in the U.S. CNW Group
Nov-27-17 08:05AM  See what the IHS Markit Score report has to say about Horizon Pharma PLC. Markit
Nov-24-17 10:42AM  ETFs with exposure to Horizon Pharma Plc : November 24, 2017 Capital Cube
Nov-22-17 05:15PM  Nuvo Pharmaceuticals Announces Appointment of Jesse Ledger as President & Chief Executive Officer CNW Group
08:05AM  See what the IHS Markit Score report has to say about Horizon Pharma PLC. Markit
Nov-13-17 12:32PM  ETFs with exposure to Horizon Pharma Plc : November 13, 2017 Capital Cube
Nov-10-17 10:00AM  Horizon Pharma Plc :HZNP-US: Earnings Analysis: Q3, 2017 By the Numbers : November 10, 2017 Capital Cube
09:30AM  Horizon Pharma plc Selected as One of Chicagos Top Workplaces by the Chicago Tribune GlobeNewswire
Horizon Pharma Public Limited Company, a biopharmaceutical company, focuses on researching, developing, and commercializing medicines that address unmet treatment needs for rare and rheumatic diseases in the United States and internationally. The company's marketed medicine portfolio consists of RAVICTI for the treatment of urea cycle disorders; PROCYSBI to treat nephropathic cystinosis; ACTIMMUNE for the treatment of chronic granulomatous disease and malignant osteopetrosis; BUPHENYL to treat urea cycle disorders; and QUINSAIR for the treatment of chronic pulmonary infections due to pseudomonas aeruginosa in cystic fibrosis patients. Its products also include KRYSTEXXA to treat chronic refractory gout; RAYOS/LODOTRA for the treatment of rheumatoid arthritis, polymyalgia rheumatic, systemic lupus erythematosus, and various other indications; PENNSAID 2% to treat pain of osteoarthritis of the knees; DUEXIS for the treatment of signs and symptoms of osteoarthritis and rheumatoid arthritis; VIMOVO to treat signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis; and MIGERGOT for the treatment of vascular headache. The company has collaboration agreement with Fox Chase Cancer Center to evaluate ACTIMMUNE in combination with PD-1/PD-L1 inhibitors in various forms of cancer; Alliance for Lupus Research to evaluate RAYOS/LODOTRA on the fatigue experienced by systemic lupus erythematosus patients; and Syneos Health, Inc. in connection with its Phase III confirmatory trial to evaluate teprotumumab for the treatment of thyroid eye disease. Horizon Pharma Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Walbert Timothy PChairman, President and CEOJan 02Option Exercise0.0049,5000497,701Jan 03 06:25 PM
open in yahoo | open in reuters | open in google